form8-k.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 10, 2007
   
 
GENPACT LIMITED
(Exact name of registrant as specified in its charter)

Bermuda
333-142875
98-0533350
 
(State or other jurisdiction
of incorporation)
 
 
(Commission
File Number)
 
 
(I.R.S. Employer
Identification No.)
 
 

Canon’s Court, 22 Victoria Street
Hamilton HM, Bermuda
(Address of Principal Executive Offices) (Zip Code)
 
Registrant’s telephone number, including area code:  (441) 295-2244
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 

 
 
 
Item 8.01. Other Events.

On August 10, 2007, Genpact Limited issued a press release announcing that the underwriters of its initial public offering have exercised their previously disclosed option to purchase 5,294,118 common shares from Genpact to cover over-allotments, which will result in an additional $70,041,181.14 of net proceeds to Genpact.  A copy of this press release, attached hereto as Exhibit 1.1, is incorporated herein by reference.


Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit 1.1
Press release dated August 10, 2007
 
 
 
 

 

 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  GENPACT LIMITED  
       
Date:  August 10, 2007
By:
/s/ Victor Guaglianone  
    Name: Victor Guaglianone  
    Title:   Senior Vice President  
           and General Counsel  
 
 
 
 

 

 
EXHIBIT INDEX


Exhibit
Description
1.1
Press release dated August 10, 2007
   

 
ex1-1.htm
 
Exhibit 1.1
 
 
 
Genpact Confirms Exercise of Over-
allotment Option
 

 
New York, NY (August 10, 2007) – Genpact Limited (NYSE: G) announced today that the underwriters of its initial public offering have exercised their previously disclosed option to purchase 5,294,118 common shares from Genpact to cover over-allotments, which will result in an additional $70,041,181.14 of net proceeds to Genpact.
 
 
 
 
FOR MORE INFORMATION, CONTACT:
 
David Jensen
david.jensen@genpact.com
203 325 8676 / 203 252 8562
Tristan B. Peniston-Bird
tpeniston-bird@gavinanderson.com
212 515 1933 / 917 499 8355